Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.65 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.51 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | CTSB | P07858 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14785027 | 0.95 | TSHR (0.59) | TSHRLMNAALDH1A1HTTPOLB | |
| SCHEMBL14060334 | 0.90 | TSHR (0.57) | TSHRLMNAALDH1A1HTTPOLB | |
| SCHEMBL3244533 | 0.89 | TSHR (0.65) | TSHRLMNAALDH1A1HTTPOLB | |
| SCHEMBL1821090 | 0.87 | TSHR (0.54) | TSHRLMNAALDH1A1HTTPOLB | |
| SCHEMBL15022885 | 0.87 | TSHR (0.54) | TSHRLMNAALDH1A1HTTPOLB | |
| SCHEMBL4566930 | 0.87 | TSHR (0.54) | TSHRLMNAALDH1A1HTTPOLB | |
| SCHEMBL8897497 | 0.86 | NFE2L2 (0.55) | TSHRLMNAALDH1A1L3MBTL1MAPT | |
| SCHEMBL30051319 | 0.85 | CYP1A2 (0.58) | TSHRLMNAALDH1A1MAPTCYP1A2 | |
| SCHEMBL8330289 | 0.85 | CYP1A2 (0.58) | TSHRLMNAALDH1A1MAPTCYP1A2 | |
| SCHEMBL14873550 | 0.85 | TSHR (0.61) | TSHRLMNAALDH1A1HTTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210355088-A1 | BRD4-JAK2 INHIBITORS | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. | 2021-11-18 | — | — | US | disclosed |
| CN-101240119-B | Carbon black reacted with diazonium salts and products | CABOT CORP | 2011-05-11 | — | — | CN | disclosed |
| EP-1225205-B1 | Carbon black reacted with diazonium salts and products | CABOT CORP (US) | 2010-10-06 | — | — | EP | disclosed |
| EP-1942156-B1 | Carbon black reacted with diazonium salts and products | CABOT CORP (US) | 2010-04-14 | — | — | EP | disclosed |
| CN-101240119-A | Carbon black reacted with diazonium salts and products | CABOT CORP (US) | 2008-08-13 | — | — | CN | disclosed |
| EP-1942156-A1 | Carbon black reacted with diazonium salts and products | Cabot Corporation (US) | 2008-07-09 | — | — | EP | disclosed |
| CN-100351320-C | Carbon black reacted with diazols, and products | CABOT CORP (US) | 2007-11-28 | — | — | CN | disclosed |
| US-7294185-B2 | In absence of exterior applies electrical current; wear resistance | CABOT CORPORATION (US) | 2007-11-13 | — | — | US | disclosed |
| EP-0799281-B2 | CARBON BLACK REACTED WITH DIAZONIUM SALTS AND PRODUCTS | CABOT CORP (US) | 2006-03-29 | — | — | EP | disclosed |
| US-6858603-B2 | Acetindine derivatives, their preparation and medicaments containing them | AVENTIS PHARMA S.A. (FR) | 2005-02-22 | — | — | US | disclosed |
| CN-1088730-C | Carbon black reacted with diazonium salts and products | CABOT CORP (US) | 2002-08-07 | — | — | CN | disclosed |
| EP-0799281-B1 | CARBON BLACK REACTED WITH DIAZONIUM SALTS AND PRODUCTS | CABOT CORP (US) | 2002-07-24 | — | — | EP | disclosed |
| EP-1225205-A2 | Carbon black reacted with diazonium salts and products | CABOT CORPORATION (US) | 2002-07-24 | — | — | EP | disclosed |
| CN-1321708-A | Carbon black reacted with diazols, and products | CABOT CORP (US) | 2001-11-14 | — | — | CN | disclosed |
| US-6042643-A | AS PIGMENT TO COLOR PLASTICS, PAPER, TEXTILE, RUBBER, AQUEOUS INKS | CABOT CORPORATION (US) | 2000-03-28 | — | — | US | disclosed |
| US-5900029-A | COLORING FIBER OR TEXTILE | CABOT CORPORATION (US) | 1999-05-04 | — | — | US | disclosed |
| US-5851280-A | Reaction of carbon black with diazonium salts, resultant carbon black products and their uses | CABOT CORPORATION (US) | 1998-12-22 | — | — | US | disclosed |
| CN-1175270-A | Carbon black reacted with diazonium salts and products | CABOT CORP (US) | 1998-03-04 | — | — | CN | disclosed |
| EP-0799281-A1 | CARBON BLACK REACTED WITH DIAZONIUM SALTS AND PRODUCTS | CABOT CORPORATION (US) | 1997-10-08 | — | — | EP | disclosed |
| WO-1996018688-A1 | CARBON BLACK REACTED WITH DIAZONIUM SALTS AND PRODUCTS | CABOT CORPORATION (US) | 1996-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210355088-A1 | BRD4-JAK2 INHIBITORS | BRD4, BICRA, JAK2 | TSHR 607/4885LMNA 4363/4885ALDH1A1 4190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.